Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport 2mL Dilution in Cervical Dystonia
NCT01753310Phase 3Completed
- Sponsor
- Ipsen
- Start
- Jan 2013
- Primary completion
- Oct 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of abobotulinumtoxinA in cervical dystonia (CD), sponsored by Ipsen. Started Jan 2013; status: completed.
02
Drugs
abobotulinumtoxinA
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT01753310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01753310.